0000899243-21-012548.txt : 20210318
0000899243-21-012548.hdr.sgml : 20210318
20210318163416
ACCESSION NUMBER: 0000899243-21-012548
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210317
FILED AS OF DATE: 20210318
DATE AS OF CHANGE: 20210318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barclay Alec
CENTRAL INDEX KEY: 0001734339
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 21754799
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-17
0
0001492674
T2 Biosystems, Inc.
TTOO
0001734339
Barclay Alec
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Operations Officer
Common Stock
2021-03-17
4
S
0
12494
1.86
D
74420
D
The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2018.
The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.82 to $1.90. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
/s/ John Sprague, Attorney-in-fact
2021-03-18